Grant: Catalyst Grant: Human Microbiome
University of British Columbia
$99,725.00
The Role of the Gastrointestinal Microbiota in Asthma
FY 2008-09
Summary
Allergic asthma is an ever-increasing problem in developed
countries and affects approximately 20% of all Canadians.
Although there are many theories about the potential cause of
asthma, the actual causes remain undefined. Recent evidence
suggests that shifts in resident microbiota (normal flora) may
play a significant role in atopic diseases such as asthma (the so-
called "hygiene hypothesis"). However, the role of the
gastrointestinal microbiota in asthma has not been explored
experimentally, and no attempt has been made to identify
microbial populations that may be associated with, or more
importantly, hinder development of asthma. In this application
we propose to explore the contribution of the microbiota to
asthma. We will use a well characterized murine model of
asthma to determine if the microbiota plays a role in this
disease. This will be achieved by varying the microbiota using
different antibiotics, characterizing resulting population shifts
using a variety of techniques, and then inducing asthma. The
microbiota of antibiotic pretreated animals will also be
reconstituted with microbiota from susceptible and resistant
populations. Collectively, these approaches will provide key
information about the role of the intestinal microbiota in
asthma, and identify a specific subset associated with asthma. It
will also provide novel insights into the effect of antibiotics on
the intestinal flora, and bring together investigators with very
different skills all working on a common problem. Ultimately
this information could be used to develop new ways of treating
asthma.
Department
Program
Catalyst Grant: Human Microbiome
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
172983
Name
Finlay Barton B
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Catalyst Grant: Human Microbiome
Projecttitle
The Role of the Gastrointestinal Microbiota in Asthma
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$99,725
Cihrequipment2
$0
Programname2
Catalyst Grant: Human Microbiome
Keyworddelim
Antibiotics; Asthma; Atopic Diseases; Intestinal Flora; Microbiota
Abstract
Allergic asthma is an ever-increasing problem in developed
countries and affects approximately 20% of all Canadians.
Although there are many theories about the potential cause of
asthma, the actual causes remain undefined. Recent evidence
suggests that shifts in resident microbiota (normal flora) may
play a significant role in atopic diseases such as asthma (the so-
called "hygiene hypothesis"). However, the role of the
gastrointestinal microbiota in asthma has not been explored
experimentally, and no attempt has been made to identify
microbial populations that may be associated with, or more
importantly, hinder development of asthma. In this application
we propose to explore the contribution of the microbiota to
asthma. We will use a well characterized murine model of
asthma to determine if the microbiota plays a role in this
disease. This will be achieved by varying the microbiota using
different antibiotics, characterizing resulting population shifts
using a variety of techniques, and then inducing asthma. The
microbiota of antibiotic pretreated animals will also be
reconstituted with microbiota from susceptible and resistant
populations. Collectively, these approaches will provide key
information about the role of the intestinal microbiota in
asthma, and identify a specific subset associated with asthma. It
will also provide novel insights into the effect of antibiotics on
the intestinal flora, and bring together investigators with very
different skills all working on a common problem. Ultimately
this information could be used to develop new ways of treating
asthma.
Competitiondate
200808
Approvedterm2
1 yr 0 mth
Pinamesdelim
Finlay, Barton B
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &Respiratory Hlth~ $50,000~ $0~Inst of Infection & Immunity~ $49,725~ $0~